Cardiovascular Outcomes with Sotagliflozin

N Engl J Med. 2021 Apr 15;384(15):1470-1471. doi: 10.1056/NEJMc2102961.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Diabetic Ketoacidosis*
  • Glycosides
  • Humans
  • Renal Insufficiency, Chronic*

Substances

  • Glycosides
  • (2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol